LYONS GARY A
Director · 4 filings · Latest: May 27, 2026
NEUROCRINE BIOSCIENCES INC
Travere Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
NBIX | LYONS GARY A | Director | May 21, 2026 | Option Exercise | $0.00 | 1,659 | — | 122,141 | |
TVTX | LYONS GARY A | Director | May 19, 2026 | Grant/Award | $0.00 | 4,000 | — | 61,500 | |
TVTX | LYONS GARY A | Director | Apr 14, 2026 | Sale | $41.07 | 8,000 | $328.6K | 57,500 | |
TVTX | LYONS GARY A | Director | Apr 14, 2026 | Option Exercise | $16.33 | 8,000 | $130.6K | 65,500 |